Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Fibrosis × contrast agent BR1 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms, Nerve Tissue 1 Neoplasms 1 Liver Neoplasms 1 Glioma 1 Glioblastoma 1 Fibrosis 1 Carcinoma, Hepatocellular 1 Brain Neoplasms 1

Interventions

esmolol 1 epigallocatechin gallate 1 contrast agent BR1 1 alpha-Tocopherol 1 Viusid 1 Sonazoid 1 Sodium Chloride 1 Simvastatin 1 Pentoxifylline 1 Iodides 1 Everolimus 1 Dietary Supplements 1 Catechin 1 2-chloro-N(6)-(3-iodobenzyl)adenosine-5'-N-methyluronamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04006275 2019-09-19

Comparing SonoVue With Sonazoid Using CEUS-LIRADS in HCC

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 3 Unknown

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡